fashion -WSS

fashion

author：hotspot 2025-09-02 08:24:20 - browse：8668

Drug shortages are a growing problem in the U.S., and a shortage of livesaving cancer drugs in particular has reached crisis levels.

On the latest episode of the “First Opinion Podcast,” oncologist Kristen Rice explains that drug shortages have been happening for several years but have been progressively worsening in the past few months. Oncologists are facing critical shortages of common, generic cancer medications and have even begun to ration care for certain patients who are able to delay treatment, according to Rice.

“Patients are already under a lot of stress — they’re dealing with a cancer diagnosis, and they’re terrified. The last thing they want to hear is that something that’s critical to controlling their cancer might not be available, and we’re wondering where the next dose is going to come from,” Rice said.

The conversation is based off Rice’s recent First Opinion, “Cancer drug shortages should have patients rioting in the streets.“

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： Cancer drug shortages should be causing more outrage
Next article： Data show record exodus of life scientists from academia

hotspot

WSS

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Why a market frenzy over new weight loss drugs defies logic

Shingles, which affected Dianne Feinstein, is on the rise

How AI can help patients find reliable information about doctors

Roivant's CEO is a star, but biotech's black hole persists

After a drawn out lobbying fight, ARPA

entertainment

fashion

Wikipedia

Psychedelics group wrestles with new pharma identity

Did you have Obamacare on your GOP debate bingo card?

Moonlake's readout produced a cash windfall. Risks remain

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

23andMe had bad news about my health. I wish a person had delivered it

Would Medicare drug price negotiations stall in a shutdown?

Sports medicine is finally prioritizing gender equality

Ionis has late

State Dept. review finds Biden bears some blame for Afghanistan failures

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Wikipedia

STAT Summit: The economic case for universal basic health care

Is there really a nursing shortage in the U.S.?

CZI to create biohub to build anti

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Smaller biotechs seek to piggyback on weight loss drug boom

ADCs take center stage as promising cancer treatments

hotspot

hotspot

knowledge

entertainment